Top

Published in:

01-01-2022 | Gastrointestinal Bleeding | Case Report

Retained Endoscope: An Unexpected but Serious Complication of Hemospray®

Authors: Raymond Shi Liang Yii, Kee Huat Chuah, Keat Seong Poh, Peng Choong Lau, Khoon Leong Ng, Shiaw Hooi Ho, Sanjiv Mahadeva

Published in: Digestive Diseases and Sciences | Issue 1/2022

Excerpt

Hemospray® (Cook Medical, Winston-Salem, North Carolina, USA) is a non-contact, endoscopic hemostatic device utilizing inert Bentonite powder that is delivered through a carbon dioxide powered delivery system [1]. Since its inception, Hemospray® has been widely utilized as an effective endoscopic hemostatic technique in the management of acute gastrointestinal hemorrhage from various etiologies. Adverse events related to the usage of Hemospray® have been reported but rare [1]. We report a case with an unexpected complication of Hemospray®—a retained endoscope within the upper gastrointestinal (UGI) tract of an adult patient post-application of Hemospray® on a bleeding gastric tumor. …

De Novo Classification Request For Hemospray® Endoscopic Hemostat. [U.S. Food and Drug Administration (FDA) Web site]. Apr 20, 2020. https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170015.pdf. Accessed 25 Apr 2020

Eisenhour DD, Brown RK. Bentonite and its impact on modern life. Elements 2009;5:83–88CrossRef

Mutneja H, Bhurwal A, Go A et al. Efficacy of hemospray in upper gastrointestinal bleeding: a systematic review and meta-analysis. J Gastrointestin Liver Dis 2020;29:69–76CrossRef

Chen YI, Wyse J, Lu Y et al. TC-325 hemostatic powder versus current standard of care in managing malignant GI bleeding: a pilot randomized clinical trial. Gastrointest Endosc 2020;91:321−328 e321

Pittayanon R, Prueksapanich P, Rerknimitr R. The efficacy of Hemospray in patients with upper gastrointestinal bleeding from tumor. Endosc Int Open 2016;4:E933–E936CrossRef

Smith LA, Stanley AJ, Bergman JJ et al. Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the survey to evaluate the application of Hemospray in the luminal tract. J Clin Gastroenterol 2014;48:e89–e92CrossRef

MAUDE Adverse Event Report: Cook Endoscopy Hemospray Endoscopic Hemostat. [U.S. Food and Drug Administration (FDA) Web site]. Mar 31, 2020. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=8386669&pc=QAU. Accessed 15 Apr 2020

Sung JJ, Luo D, Wu JC et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011;43:291–295CrossRef

Marshall LR. Hemospray endoscopic hemostat. Biomed Saf Stand 2019;49:164

10.

Vitali F, Naegel A, Atreya R et al. Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding. World J Gastroenterol 2019;25:1592–1602CrossRef

Title: Retained Endoscope: An Unexpected but Serious Complication of Hemospray®
Authors: Raymond Shi Liang Yii
Kee Huat Chuah
Keat Seong Poh
Peng Choong Lau
Khoon Leong Ng
Shiaw Hooi Ho
Sanjiv Mahadeva
Publication date: 01-01-2022
Publisher: Springer US
Keywords: Gastrointestinal Bleeding
Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Published in: Digestive Diseases and Sciences / Issue 1/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-021-06835-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Retained Endoscope: An Unexpected but Serious Complication of Hemospray®

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Update: Innate Lymphoid Cells in Inflammatory Bowel Disease

Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19

CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells

Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, “Prediabetes,” Diabetes and Atherosclerosis

Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study

Use of Artificial Intelligence in the Prediction of Malignant Potential of Gastric Gastrointestinal Stromal Tumors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page